Increasing evidence indicates that multiple actions of the immune system are closely intertwined with the development of depression and subsequent recovery processes. One of these interactions is substantial evidence that the T H 17 subtype of CD4 + T cells promotes susceptibility to depression-like behaviors in mice. (Beurel and Lowell, 2017) includes the correlative association that depressed patients have elevated blood levels of T H 17 cells (Chen et al., 2011) , in vitro activation of CD4 cells isolated from patients with generalized anxiety disorder induces them to acquire a T H 17 phenotype (Ferreira et al., 2011; Vieira et al., 2010) , and patients with autoimmune diseases with elevated T H 17 cells often exhibit comorbid depression (Kurd et al., 2010; Patten et al., 2017) . Consistent with these findings, IL-17A was elevated in some (Chen et al., 2011; Davami et al., 2016) , but not all (Kim et al., 2013; Liu et al., 2012) , depressed patients, IL-17A levels predicts treatment response to certain antidepressants (Jha et al., 2017) , administration of IL-17A in rodents promotes depressive-like behaviors (Nadeem et al., 2017) , and anti-IL-17A therapy induces remission of depression in 40% of psoriasis patients experiencing moderately severe depression (Griffiths et al., 2017 
